ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
Philip Kioko Ndonye, 1 1, Samuel Nii Adu Tagoe, 1 1
Purpose : Owing to the missing recent data regarding cancer case volumes in Kenyan hospitals since 2012, the aim of the study was to fill the gap by providing data for two hospitals in Nairobi, the post year 2012. The general situation of radiation oncology a…
Yafei Bao, Lei Zhang, Liang Zhen, Bo Jiang, Chen Yang
Objective: To study the effect of different pressure artificial pneumothorax on total endoscopic radical esophagectomy during and after an operation. Methods: From 2019 to 2021, 64 patients with esophageal cancer underwent video-assisted thoracoscopic surgery…
Weijin Wei, Xiaoxiao Huang, Linjuan Zeng, Jiudi Zhong
Purpose: Use the psychological resilience development model to formulate effective nursing measures, and explore the impact of relevant nursing measures on the psychological resilience and post-traumatic growth of patients. Methods: Using a general data sheet…
Xue Chen, Chen Yin, Qingfen Liu, Jianxiang Liu
Objective: Radiotherapy has been widely used to treat lung cancer. However, non-small lung cancer cells are insensitive to radiation, diminishing their radiotherapy effects. Although the radiosensitivity of the non-small lung cancer cells was reported to be e…
Arouna Adama Doumbia, Maiga Amadou, Bah Amadou, Saye Zakari, Coulibaly Bourama, Diarra Bourama, Togo Adégné
Primary breast lymphomas are rare. They are defined by the involvement of one or both breasts. This is the first site affected or mainly affected with the exception of ipsilateral axillary involvement. Due to the absence of specific clinical and radiological…
Cyril Kamadjou, Divine Enoru Eyongeta, Annie Kameni, Achille Mbassi, Fru Angwafor
Background and Objective : Bladder cancer frequently occurs between the ages of 50 years and 70 years and rarely occurs before the age of 40 years. It accounts for 1% - 4% of all cases of cancer. This study focuses on the clinical, etiological, histological,…
Kenza Benali, Houda Benmessaoud, Halima Ahmut, Sanaa El Majjaoui, Tayeb Kebdani, Khalid Hassouni, Hanan El Kacemi, Noureddine Benjaafar
Background: The coronavirus disease 2019 (COVID-19) pandemic has led t o the imposition of a strict nationwide lockdown, which has affected all aspects of healthcare, including the delivery of standard care to cancer patients. Objective: The aim of this study…
Nioka Pierre Xavier Sia, Tarik Chekrine, Mouna Bourhafour, Karima Ouadii, Zineb Bouchbika, Nadia Benchakroun, Hassan Jouhadi, Nezha Tawfiq, Abdellatif Benider, Farida Marnissi, Abdellah Madani, Mehdi Karkouri, Souha Sahraoui
Background and Aim : Primary testicular lymphoma (PTL) is a rare form of extranodal non-Hodgkin’s lymphoma. It represents for 1% - 2% of non - Hodgkin’s lymphoma, and mostly affects the elderly. We describe an interesting case of PTL managed by a combined mul…
C. F. S. Ngatali, A. F. BoLenga Liboko, Y. Mabiala, D. Moukassa, J. B. Nkoua-Mbon
Introduction: The objective of our study was to determine the prevalence of hem atological toxicity during breast cancer chemotherapy. Patients and Meth ods: This was a cross-sectional descriptive study that took place in the canc erology and internal medicin…
Guangping Chen, William Liu, Bingfang Yan
In vitro 3D cancer spheroids (tumoroids) exhibit a drug resistance profile similar to that found in solid tumors. 3D spheroid culture methods recreate more physiologically relevant microenvironments for cells. Therefore, these models are more appropriate for…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).